GW24-e2206 Aliskiren and amlodipine in the management of essential hypertension: Meta-analysis of randomised controlled trials

Objectives Aliskiren is a novel renin-angiotensinaldosterone system (RAAS) inhibitor, the combination therapy of aliskiren andamlodipine for blood pressure control have been reported recently. The primary objective of this analysis is to review recently reported randomised controlled trials (RCTs) t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Heart (British Cardiac Society) 2013-08, Vol.99 (Suppl 3), p.A61-A61
Hauptverfasser:	Yukai Chen Ken, Liu, Kou, Xun, Han, Yu, Zhou, Lin, Zeng, Chunyu
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!